Although everolimus as monotherapy showed a strong antitumor effect and did not induce an increase in phosphorilated Akt in our chondrosarcoma model one cannot put aside the possibility that resistance could emerge in response to long term mTORC1 inhibition. Here, AKT1 is linked to chondrosarcoma.